The Rochester, Minn.-based health system will begin rolling out the generative AI tool starting with approximately 2,000 physicians who serve over 1 million patients annually across a range of specialties and care settings.
The enterprise-wide implementation follows a rigorous evaluation process, during which Mayo Clinic evaluated Abridge’s tool with a rigorous clinical note quality assessment, seeking to ensure that the notes it generated met Mayo standards.
“At Mayo Clinic, we are committed to leveraging innovative AI platforms to improve both clinicians’ well-being and provide high-quality, patient-centered care,” said Amy Williams, MD, executive dean of the Practice at Mayo Clinic. “This collaboration aims to enhance our continuous innovation and empowers our clinicians to focus on what matters most — our patients.”
In addition to its work with physicians, Mayo Clinic and Abridge partnered in July 2024 to develop a generative AI tool tailored for nurses, which will be the first of its kind.
“Mayo Clinic’s ethos for adopting high-quality innovation complements our drive to continuously enhance our platform to meet the unique needs of clinicians across diverse specialties, languages and care settings,” Abridge Founder and CEO Shiv Rao, MD, said.
Mayo Clinic joins a growing roster of Abridge’s enterprise-wide partners, which include Duke Health, Johns Hopkins Medicine, Corewell Health and a recently expanded collaboration with UChicago Medicine.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.